Chengdu Kanghua Biological Products Co., Ltd.

SZSE:300841 Stock Report

Market Cap: CN¥6.9b

Chengdu Kanghua Biological Products Future Growth

Future criteria checks 2/6

Chengdu Kanghua Biological Products is forecast to grow earnings and revenue by 15.6% and 13.8% per annum respectively. EPS is expected to grow by 15.4% per annum. Return on equity is forecast to be 17% in 3 years.

Key information

15.6%

Earnings growth rate

15.4%

EPS growth rate

Biotechs earnings growth32.9%
Revenue growth rate13.8%
Future return on equity17.0%
Analyst coverage

Low

Last updated26 May 2024

Recent future growth updates

Recent updates

We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt

Jun 26
We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt

Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Feb 27
Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Earnings and Revenue Growth Forecasts

SZSE:300841 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,379884N/A8865
12/31/20252,127797N/A6865
12/31/20241,868709N/A8095
3/31/20241,611553523656N/A
12/31/20231,577509417574N/A
9/30/20231,382484233440N/A
6/30/20231,42153172384N/A
3/31/20231,458568-85324N/A
1/1/20231,447598-224195N/A
9/30/20221,567729-246138N/A
6/30/20221,400893-31083N/A
3/31/20221,322864-27482N/A
1/1/20221,292829-185130N/A
9/30/2021993648-20397N/A
6/30/20211,13647835213N/A
3/31/20211,119444158302N/A
12/31/20201,039408234370N/A
9/30/20201,085442237327N/A
6/30/2020739285188263N/A
3/31/2020581216123166N/A
12/31/2019555187159183N/A
9/30/2019425101170189N/A
12/31/20185591542357N/A
12/31/201726274N/A90N/A
12/31/2016937N/A3N/A
12/31/20157112N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300841's forecast earnings growth (15.6% per year) is above the savings rate (2.9%).

Earnings vs Market: 300841's earnings (15.6% per year) are forecast to grow slower than the CN market (22.2% per year).

High Growth Earnings: 300841's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300841's revenue (13.8% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 300841's revenue (13.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 300841's Return on Equity is forecast to be low in 3 years time (17%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.